HOOKIPA Pharma Inc. financial data

Symbol
HOOK on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 374 % +8.92%
Debt-to-equity 47.7 % -39.2%
Return On Equity -55.5 % +35.3%
Return On Assets -37.6 % +21.8%
Operating Margin -117 % +75.9%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 57M USD -20.5%
Weighted Average Number of Shares Outstanding, Basic 12.5M shares +32.6%
Weighted Average Number of Shares Outstanding, Diluted 12.5M shares +32.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 43.9M USD +118%
Research and Development Expense 68.5M USD -20.7%
General and Administrative Expense 20.2M USD +8.55%
Costs and Expenses 95.4M USD -19%
Operating Income (Loss) -51.5M USD +47.3%
Nonoperating Income (Expense) 7.85M USD -52.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43.6M USD +46.3%
Income Tax Expense (Benefit) -106K USD -129%
Net Income (Loss) Attributable to Parent -43.5M USD +46.7%
Earnings Per Share, Basic -3.47 USD/shares +59.8%
Earnings Per Share, Diluted -3.47 USD/shares +59.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.7M USD -66.1%
Accounts Receivable, after Allowance for Credit Loss, Current 290K USD -43.2%
Assets, Current 80.7M USD -45.2%
Property, Plant and Equipment, Net 179K USD -97.7%
Operating Lease, Right-of-Use Asset 885K USD -83.8%
Other Assets, Noncurrent 660K USD -39.6%
Assets 82.5M USD -48.8%
Accounts Payable, Current 8.69M USD -30.5%
Contract with Customer, Liability, Current 4.65M USD -75.6%
Liabilities, Current 24.7M USD -41.3%
Contract with Customer, Liability, Noncurrent 2.62M USD -91.4%
Operating Lease, Liability, Noncurrent 323K USD -91.5%
Other Liabilities, Noncurrent 5.63M USD -6.43%
Liabilities 31.3M USD -56.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.09M USD +35.9%
Retained Earnings (Accumulated Deficit) -413M USD -11.8%
Stockholders' Equity Attributable to Parent 51.2M USD -43%
Liabilities and Equity 82.5M USD -48.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.2M USD -748%
Net Cash Provided by (Used in) Financing Activities -135K USD +81.6%
Net Cash Provided by (Used in) Investing Activities -116K USD +57.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 39.9M USD -66.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD
Deferred Tax Assets, Valuation Allowance 93.4M USD +4.56%
Deferred Tax Assets, Gross 97.9M USD +3.72%
Operating Lease, Liability 875K USD -83.8%
Payments to Acquire Property, Plant, and Equipment 116K USD -57.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.7M USD +50.6%
Lessee, Operating Lease, Liability, to be Paid 912K USD -84.4%
Property, Plant and Equipment, Gross 6.07M USD -65.5%
Operating Lease, Liability, Current 552K USD -66.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 208K USD -87.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 558K USD -66.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 37K USD -91%
Lessee, Operating Lease, Liability, to be Paid, Year Three 73K USD -94.6%
Deferred Tax Assets, Operating Loss Carryforwards 94.3M USD +7.81%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 73K USD -94%
Additional Paid in Capital 469M USD +0.43%
Depreciation, Depletion and Amortization 640K USD -30.5%
Deferred Tax Assets, Net of Valuation Allowance 4.49M USD -11.1%
Share-based Payment Arrangement, Expense 2.01M USD -14.1%
Interest Expense 197K USD -65.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%